Cytokinetics (CYTK) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Cytokinetics

    NASDAQ: CYTK · Real-Time Price · USD
    50.40
    2.57 (5.37%)
    At close: Sep 26, 2025, 3:59 PM
    51.30
    1.79%
    After-hours: Sep 26, 2025, 07:49 PM EDT

    Cytokinetics Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 94.86M 113.02M 65.58M 112.67M
    Short-Term Investments
    		 981.16M 501.8M 717M 358.97M
    Long-Term Investments
    		 145.06M 40.53M 46.71M 152.05M
    Other Long-Term Assets
    		 7.71M 8M 9.69M 7.19M
    Receivables
    		 16.65M 1.28M 147K 51.82M
    Inventory
    		 n/a n/a -147K n/a
    Other Current Assets
    		 15.28M n/a 12.61M n/a
    Total Current Assets
    		 1.11B 628.05M 795.19M 535.67M
    Property-Plant & Equipment
    		 140.97M 147.74M 163.19M 146.41M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 293.73M 196.26M 219.59M 305.65M
    Total Assets
    		 1.4B 824.32M 1.01B 841.32M
    Account Payables
    		 20.37M 21.51M 25.61M 21.09M
    Deferred Revenue
    		 52.37M n/a n/a 34.37M
    Short-Term Debt
    		 11.52M 10.08M 958K 14.86M
    Other Current Liabilities
    		 21.11M 39.81M 23.45M -28.25M
    Total Current Liabilities
    		 179.67M 102.68M 84.62M 71.86M
    Long-Term Debt
    		 645.6M 607.37M 609.62M 142.84M
    Other Long-Term Liabilities
    		 599.19M 380.16M 301.55M 183.53M
    Total Long-Term Liabilities
    		 1.36B 1.11B 1.04B 525.6M
    Total Liabilities
    		 1.54B 1.21B 1.12B 597.46M
    Total Debt
    		 788.68M 755.77M 749.34M 269.93M
    Book Value
    		 -135.37M -386.32M -107.9M 243.86M
    Book Value Per Share
    		 -1.21 -4 -1.2 3.17
    Common Stock
    		 118K 102K 94K 84K
    Retained Earnings
    		 -2.7B -2.11B -1.59B -1.21B
    Comprehensive Income
    		 2.4M -10K -3.59M -869K
    Shareholders Equity
    		 -135.37M -386.32M -107.9M 243.86M
    Total Investments
    		 1.13B 542.33M 763.7M 511.02M

    Add to Watchlist